EP3378862
DÍHÝDRÓPÝRÍMÍDÍNÓÍSÓKÍNÓLÍNÓN OG LYFJAFRÆÐILEGAR SAMSETNINGAR ÞAR AF TIL MEÐFERÐAR VIÐ HEILA- OG MÆNUSIGGI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.12.2012EP published:
16.3.2022EP application number:
17184834.4
EP translation filed:
8.4.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
19.12.2032Expiry date:
19.12.2023
Title in English:
DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF MULTIPLE SCLEROSISLanguage of the patent:
English
Timeline
Today
20.12.2012EP application
16.3.2022EP Publication
8.4.2022Translation submitted
15.5.2022Registration published
19.12.2023Expires
Owner
Name:
Galapagos N.V.Address:
Generaal de Wittelaan L11 A3, 2800 Mechelen, BE
Inventor
Name:
LABÉGUÈRE, Frédéric GilbertAddress:
93220 Gagny, FR
Name:
NEWSOME, Gregory John RobertAddress:
93230 Romainville, FR
Name:
ALVEY, Luke JonathanAddress:
93230 Romainville, FR
Name:
SANIÈRE, Laurent Raymond MauriceAddress:
93230 Romainville, FR
Name:
FLETCHER, Stephen RobertAddress:
Bishops Stortford, CM22 7EG, GB
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161578979 PDate:
22.12.2011Country:
US
Classification
Categories:
C07D 471/04, A61K 31/529, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 9.11.2022
Expires: 19.12.2023
Payer: Árnason Faktor ehf.